Oleg Nodelman’s EcoR1 Capital disclosed a new $2.3 Transcept Pharmaceuticals Inc (NASDAQ:TSPT) on Friday. EcoR1 Capital reported a 5.5% passive stake in this specialty pharmaceutical company. Oleg Nodelman cut his teeth at Mark Lampert’s BVF Inc working as an analyst and portfolio manager for more than a decade. Jim Roumell has a huge position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT). Mark Lampert also initiated a brand new $300 thousand position in the stock during the first quarter.
At the end of 2013 Oleg Nodelman disclosed a large position in Kindred Biosciences Inc (NASDAQ:KIN). The stock performed well in the first few months of this year. However, it gave back its returns later in the year and is now down more than 5% for the year.